speaker-photo

Prof. Alaa Kandil

14:30-15:00

Friday 3-5-2024 Day 1

Oncologists/pathologists dialogue TILS and descalation of systemic therapy in early breast cancer?

16:45-17:30

Friday 3-5-2024 Day 1

Transition from hormonal-based to chemotherapy in metastatic BC??

  • Patients with early progression on CDK4-6 inhibitors: What is next??
  • When to start ADCs/olaparib in patients who had visceral crisis?? Can be upfront??
  • Any role of hormonal monotherapy after CDK4-6 inhibitors??
  • Biomarkers to guide subsequent therapies
  • Can we use one ADC after previous ADC??

Moderator:  Dr. Ahmed Alfaraj

Panel: